BioLife Solutions (BLFS) CMO uses shares to cover tax bill

Rhea-AI Filing Summary

BioLife Solutions Inc. reported an insider tax-withholding transaction by Chief Marketing Officer Todd Berard. On the release of restricted stock units, 1,879 shares of common stock were withheld by the company to cover his tax obligations. After this non-market disposition, Berard directly holds 164,061 shares of BioLife Solutions common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Berard Todd

Role Chief Marketing Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	1,879	$19.12	$36K

Holdings After Transaction: Common Stock — 164,061 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Berard Todd

(Last) (First) (Middle)

3303 MONTE VILLA PARKWAY

SUITE 310

(Street)

BOTHELL WASHINGTON 98021

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BIOLIFE SOLUTIONS INC [ BLFS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/19/2026		F		1,879	D	$19.12(1)	164,061	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

Remarks:

	/s/ Todd Berard	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did BioLife Solutions (BLFS) disclose for Todd Berard?

BioLife Solutions disclosed that Chief Marketing Officer Todd Berard had 1,879 common shares withheld to satisfy tax obligations arising from the release of restricted stock units. This was a tax-withholding disposition, not an open-market purchase or sale of shares.

How many BioLife Solutions shares were withheld for Todd Berard’s taxes?

A total of 1,879 BioLife Solutions common shares were withheld to cover Todd Berard’s tax liability related to restricted stock units vesting. The withholding price was $19.12 per share, reflecting a non-market mechanism to satisfy personal tax obligations on equity compensation.

How many BioLife Solutions (BLFS) shares does Todd Berard hold after this Form 4?

Following the tax-withholding disposition, Todd Berard directly holds 164,061 shares of BioLife Solutions common stock. This figure reflects his remaining position after 1,879 shares were withheld by the company to meet tax obligations tied to restricted stock unit vesting.

Was the BioLife Solutions Form 4 transaction an open-market sale or purchase?

The Form 4 transaction was not an open-market sale or purchase. It was coded as an F transaction, meaning 1,879 shares were withheld by BioLife Solutions to pay Todd Berard’s tax obligations from restricted stock unit release, a routine compensation-related event.

What does transaction code F mean in the BioLife Solutions (BLFS) Form 4?

Transaction code F indicates a payment of exercise price or tax liability by delivering securities. For BioLife Solutions, it shows 1,879 shares were withheld from Todd Berard’s vested restricted stock units to satisfy taxes, rather than him selling shares in the open market.